Patent · US Active

Method for treatment of rosacea

US11541026B2 · kind B2 · utility

2Cited by

7References

12Claims

0Family size

Assignee

Sol-Gel Technologies Ltd. · IL

Inventors

Moshe ARKIN · Kfar Shmaryahu, IL
Karine NEIMANN · Nes Ziona, IL
Ofer Toledano · Kfar Sava, IL

Key dates

Filing date	Dec 3, 2021
Grant date	Jan 3, 2023
Priority date	—
Expiry date	Dec 3, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61Q19/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A regimen is described for the therapeutic treatment of rosacea. The regimen includes topically applying a pharmaceutical composition to the skin of a subject in need of said treatment. The pharmaceutical composition includes from about 2.5% to about 10% benzoyl peroxide as the only active ingredient, and a pharmaceutically acceptable carrier or excipient. The regimen achieves, in a group of such subjects, a primary measure of success of at least about 9%, at least about 25%, at least about 40%, or at least about 47%, after application of said pharmaceutical composition once daily for at least about 2 weeks, at least about 4 weeks, at least about 8 weeks, or at least about 12 weeks, respectively.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.